I was appointed as a consultant gynaecological oncologist at the University College London Hospital in 2002. University College Hospital is the centre for gynaecological cancer for the North London Cancer Network. I have previously been the clinical lead for gynaecological cancer at UCLH and the chair of the North London Cancer Network Gynaecology Tumour Board.
I specialise in the treatment of women with gynaecological cancer and have a particular interest in quality of life in young women after treatment for cancer. I obtained my medical degree from University College Hospitals London where I was distinguished with a certificate of merit in surgery. As part of my training in obstetrics and gynaecology, I worked in many of London’s leading hospitals and obtained the MRCOG.
Following this, I undertook a two-year research program into the immunology of the female genital tract at the Royal Free Hospital, London. I was awarded an MD for my thesis by the University of London.
I undertook subspecialty training in gynaecological oncology at St Michael’s Hospital, the women’s teaching hospital of Bristol University and was awarded subspecialty accreditation by the Royal College of Obstetricians and Gynaecologists. I am also an accredited minimally invasive surgeon and offer women the minimally invasive approach to surgery for gynaecological cancer where appropriate. I have received several prizes and awards for my work at various stages of my career.
I have an interest in public education and awareness raising nationally and globally and work with a number of charities and media organisations to implement this.
As well as specilaising in the treatment of all gynaecological cancers, I provide prevention, screening and diagnostic services via a rapid access and colposcopy clinic.
Care for women with gynaecological cancer at UCLH is provided by a multidisciplinary team of experts who work closely together to ensure that women receive the highest quality treatment.
My clinics are the joint oncology clinic and a rapid access/colposcopy clinic
Uwe Güth, Wendy A. Ella, Adeola Olaitan, Richard J. Hadwin , Rupali Arora, , Mary McCormack, Total vaginal necrosis: a representative example of underreporting severe late toxicity following concomitant chemoradiation for cervical cancer Int J Gynecol Cancer 2010;20: 54Y60)
O’Gorman T. Olaitan A Primary Malignant Melanoma arising in an Ovarian Cystic Teratoma European Journal of Gynaecological Oncology no1 Jan 2009
O’Gorman T, Macdonald N, Mould T, Cutner A, Hurley R, Olaitan A Total Laparoscopic Hysterectomy in Morbidly Obese Woman with endometrial Cancer: Anaesthetic & Surgical Complications; European Journal of Gynaecological Oncology no 2 2009
Somoye G, Mocroft A, Olaitan A. Analysis of the incidence and mortality of vulval cancer in women in South East England 1960-1999
Archives of Gynecology & Obstetrics 2008 May 17. [Epub ahead of print] PMID: 18488239 Volume 279, Number 2 2009 113-117
Pamela Wynne, Claire Newton, Jonathan A Ledermann, Adeola Olaitan, Timothy A Mould and John A Hartley Enhanced Repair Of DNA Interstrand Cross-Linking In Ovarian Cancer Cells from Patients following Treatment with Platinum-Based Chemotherapy; British Journal of Cancer (2007) 97, 927-933
Yu C, Chiu C, McCormack M, Olaitan A Delayed Diagnosis of Cervical Cancer in Young Women, Journal of Obstetrics and Gynaecology, May 2005; 25(4): 367 – 370
Yu C KH, Cutner A, Mould T, Olaitan A Total laparoscopic hysterectomy as a primary surgical treatment for endometrial cancer in morbidly obese women. BJOG 2005(112):1150-117
Review Articles & book chapters:
D McGregor, A Olaitan Fighting cervical cancer in developing countries The Obstetrician & Gynaecologist January 2010
Olaitan A, McCormack M. Centralisation of services for the management of ovarian cancer: arguments for. BJOG 2007;114:1188–1190.
Other immunosuppressive disorders and cervical pre-malignancy and neoplasia Adeola Olaitan, MD, MRCOG, Theresa Freeman-Wang, MRCOG, In ‘The Cervix’ Eds Jordan, Singer JonesIII & Shafi 2007